{"data":{"id":"us-ok/okla.-stat.-tit.-63-63-2-204","jurisdiction":"us-ok","citation":"Okla. Stat. tit. 63, § 63-2-204","heading":"Schedule I","body":"The controlled substances listed in this section are included in\n\nSchedule I and include any material, compound, mixture or\n\npreparation that contains any quantity of the following\n\nhallucinogenic substances, their salts, isomers and salts of\n\nisomers, unless specifically excepted, when the existence of these\n\nsalts, isomers and salts of isomers is possible within the specific\n\nchemical designation.\n\nA. Any of the following opiates including their isomers,\n\nesters, ethers, salts, and salts of isomers, esters, and ethers,\n\nunless specifically excepted, when the existence of these isomers,\n\nesters, ethers, and salts is possible within the specific chemical\n\ndesignation:\n\n1. Acetylmethadol;\n\n2. Allylprodine;\n\n3. Alphacetylmethadol;\n\n4. Alphameprodine;\n\n5. Alphamethadol;\n\n6. Benzethidine;\n\n7. Betacetylmethadol;\n\n8. Betameprodine;\n\n9. Betamethadol;\n\n10. Betaprodine;\n\n11. Clonitazene;\n\n12. Dextromoramide;\n\n13. Dextrorphan (except its methyl ether);\n\n14. Diampromide;\n\n15. Diethylthiambutene;\n\n16. Dimenoxadol;\n\n17. Dimepheptanol;\n\n18. Dimethylthiambutene;\n\n19. Dioxaphetyl butyrate;\n\n20. Dipipanone;\n\n21. Ethylmethylthiambutene;\n\n22. Etonitazene;\n\n23. Etoxeridine;\n\n24. Furethidine;\n\n25. Hydroxypethidine;\n\n26. Isotonitazene;\n\n27. Ketobemidone;\n\n28. Levomoramide;\n\n29. Levophenacylmorphan;\n\n30. Metonitazene;\n\n31. Morpheridine;\n\n32. N-desethyl isotonitazene;\n\n33. N-pyrrolidino protonitazene;\n\n34. Noracymethadol;\n\n35. Norlevorphanol;\n\n36. Normethadone;\n\n37. Norpipanone;\n\n38. Phenadoxone;\n\n39. Phenampromide;\n\n40. Phenomorphan;\n\n41. Phenoperidine;\n\n42. Piritramide;\n\n43. Proheptazine;\n\n44. Properidine;\n\n45. Protonitazene;\n\n46. Racemoramide; or\n\n47. Trimeperidine.\n\nB. Any of the following opium derivatives, their salts,\n\nisomers, and salts of isomers, unless specifically excepted, when\n\nthe existence of these salts, isomers, and salts of isomers is\n\npossible within the specific chemical designation:\n\n1. Acetorphine;\n\n2. Acetyldihydrocodeine;\n\n3. Benzylmorphine;\n\n4. Codeine methylbromide;\n\n5. Codeine-N-Oxide;\n\n6. Cyprenorphine;\n\n7. Desomorphine;\n\n8. Dihydromorphine;\n\n9. Etorphine;\n\n10. Heroin;\n\n11. Hydromorphinol;\n\n12. Methyldesorphine;\n\n13. Methylhydromorphine;\n\n14. Morphine methylbromide;\n\n15. Morphine methylsulfonate;\n\n16. Morphine-N-Oxide;\n\n17. Myrophine;\n\n18. Nicocodeine;\n\n19. Nicomorphine;\n\n20. Normorphine;\n\n21. Phoclodine;\n\n22. Thebacon;\n\n23. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-acetamide\n\n(Acetyl fentanyl);\n\n24. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-butenamide\n\n(Crotonyl fentanyl);\n\n25. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-2-\n\nfurancarboxamide (Furanyl fentanyl);\n\n26. N-phenyl-1-(2-phenylethyl)-4-piperidinamine (4-ANPP);\n\n27. N-(1-phenethylpiperidin-4-yl)-N-\n\nphenylcyclopropanecarboxamide (Cyclopropyl fentanyl); or\n\n28. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-butanamide\n\n(Butyrl fentanyl).\n\nC. Any material, compound, mixture, or preparation which\n\ncontains any quantity of the following hallucinogenic substances,\n\ntheir salts, isomers, and salts of isomers, unless specifically\n\nexcepted, when the existence of these salts, isomers, and salts of\n\nisomers is possible within the specific chemical designation:\n\n1. Methcathinone;\n\n2. 3, 4-methylenedioxy amphetamine;\n\n3. 3, 4-methylenedioxy methamphetamine;\n\n4. 5-methoxy-3, 4-methylenedioxy amphetamine;\n\n5. 3, 4, 5-trimethoxy amphetamine;\n\n6. Bufotenine;\n\n7. Diethyltryptamine;\n\n8. Dimethyltryptamine;\n\n9. 4-methyl-2, 5-dimethoxyamphetamine;\n\n10. Ibogaine;\n\n11. Lysergic acid diethylamide;\n\n12. Marijuana;\n\n13. Mescaline;\n\n14. N-benzylpiperazine;\n\n15. N-ethyl-3-piperidyl benzilate;\n\n16. N-methyl-3-piperidyl benzilate;\n\n17. Psilocybin;\n\n18. Psilocyn;\n\n19. 2, 5 dimethoxyamphetamine;\n\n20. 4 Bromo-2, 5-dimethoxyamphetamine;\n\n21. 4 methoxyamphetamine;\n\n22. Cyclohexamine;\n\namine;\n\n10. Ibogaine;\n\n11. Lysergic acid diethylamide;\n\n12. Marijuana;\n\n13. Mescaline;\n\n14. N-benzylpiperazine;\n\n15. N-ethyl-3-piperidyl benzilate;\n\n16. N-methyl-3-piperidyl benzilate;\n\n17. Psilocybin;\n\n18. Psilocyn;\n\n19. 2, 5 dimethoxyamphetamine;\n\n20. 4 Bromo-2, 5-dimethoxyamphetamine;\n\n21. 4 methoxyamphetamine;\n\n22. Cyclohexamine;\n\n23. Salvia Divinorum;\n\n24. Salvinorin A;\n\n25. Thiophene Analog of Phencyclidine. Also known as: 1-(1-(2-\n\nthienyl) cyclohexyl) piperidine; 2-Thienyl Analog of Phencyclidine;\n\nTPCP, TCP;\n\n26. Phencyclidine (PCP);\n\n27. Pyrrolidine Analog for Phencyclidine. Also known as 1-(1-\n\nPhenylcyclohexyl) - Pyrrolidine, PCPy, PHP;\n\n28. 1-(3-trifluoromethylphenyl) piperazine;\n\n29. Flunitrazepam;\n\n30. B-hydroxy-amphetamine;\n\n31. B-ketoamphetamine;\n\n32. 2,5-dimethoxy-4-nitroamphetamine;\n\n33. 2,5-dimethoxy-4-bromophenethylamine;\n\n34. 2,5-dimethoxy-4-chlorophenethylamine;\n\n35. 2,5-dimethoxy-4-iodoamphetamine;\n\n36. 2,5-dimethoxy-4-iodophenethylamine;\n\n37. 2,5-dimethoxy-4-methylphenethylamine;\n\n38. 2,5-dimethoxy-4-ethylphenethylamine;\n\n39. 2,5-dimethoxy-4-fluorophenethylamine;\n\n40. 2,5-dimethoxy-4-nitrophenethylamine;\n\n41. 2,5-dimethoxy-4-ethylthio-phenethylamine;\n\n42. 2,5-dimethoxy-4-isopropylthio-phenethylamine;\n\n43. 2,5-dimethoxy-4-propylthio-phenethylamine;\n\n44. 2,5-dimethoxy-4-cyclopropylmethylthio-phenethylamine;\n\n45. 2,5-dimethoxy-4-tert-butylthio-phenethylamine;\n\n46. 2,5-dimethoxy-4-(2-fluoroethylthio)-phenethylamine;\n\n47. 5-methoxy-N, N-dimethyltryptamine;\n\n48. N-methyltryptamine;\n\n49. A-ethyltryptamine;\n\n50. A-methyltryptamine;\n\n51. N, N-diethyltryptamine;\n\n52. N, N-diisopropyltryptamine;\n\n53. N, N-dipropyltryptamine;\n\n54. 5-methoxy-a-methyltryptamine;\n\n55. 4-hydroxy-N, N-diethyltryptamine;\n\n56. 4-hydroxy-N, N-diisopropyltryptamine;\n\n57. 5-methoxy-N, N-diisopropyltryptamine;\n\n58. 4-hydroxy-N-isopropyl-N-methyltryptamine;\n\n59. 3,4-Methylenedioxymethcathinone (Methylone);\n\n60. 3,4-Methylenedioxypyrovalerone (MDPV);\n\n61. 3-Methylmethcathinone (Metaphedrone);\n\n62. 4-Methylmethcathinone (Mephedrone);\n\n63. 4-methoxymethcathinone;\n\n64. 4-Fluoromethcathinone;\n\n65. 3-Fluoromethcathinone;\n\n66. 1-(8-bromobenzo 1,2-b;4,5-b’ difuran-4-yl)-2-aminopropane;\n\n67. 2,5-Dimethoxy-4-chloroamphetamine;\n\n68. 4-Methylethcathinone;\n\n69. Pyrovalerone;\n\n70. N,N-diallyl-5-methoxytryptamine;\n\n71. 3,4-Methylenedioxy-N-ethylcathinone (Ethylone);\n\n72. B-keto-N-Methylbenzodioxolylbutanamine (Butylone);\n\n73. B-keto-Methylbenzodioxolylpentanamine (Pentylone);\n\n74. Alpha-Pyrrolidinopentiophenone;\n\n75. 4-Fluoroamphetamine;\n\n76. Pentedrone;\n\n77. 4’-Methyl-a-pyrrolidinohexaphenone;\n\n78. 2,5-dimethoxy-4-(n)-propylphenethylamine;\n\n79. 2,5-dimethoxyphenethylamine;\n\n80. 1,4-Dibenzylpiperazine;\n\n81. N,N-Dimethylamphetamine;\n\n82. 4-Fluoromethamphetamine;\n\n83. 4-Chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine\n\n(25C-NBOMe);\n\n84. 4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine\n\n(25I-NBOMe);\n\n85. 4-Bromo-2,5-dimethoxy-N-(2-methoxybenzy)phenethylamine\n\n(25B-NBOMe);\n\n86. 1-(4-Fluorophenyl)piperazine;\n\n87. Methoxetamine;\n\n88. 3,4-dichloro-N[2-dimethylamino)cyclohexyl]-N-\n\nmethylbenzamide;\n\n89. N-ethyl hexadrone;\n\n90. Isopropyl-U-47700;\n\n91. Para-fluorobutyrl fentanyl;\n\n92. Para-fluorofentanyl (pFF);\n\n93. Fluoro isobutryrl fentanyl;\n\n94. 3-Hydroxy Phencyclidine (PCP);\n\n95. 3-methoxy Phencyclidine (PCP);\n\n96. Flualprazolam; or\n\n97. Flubromazolam.\n\nD. Unless specifically excepted or unless listed in a different\n\nschedule, any material, compound, mixture, or preparation which\n\ncontains any quantity of the following substances having stimulant\n\nor depressant effect on the central nervous system:\n\n1. Fenethylline;\n\n2. Mecloqualone;\n\n3. N-ethylamphetamine;\n\n4. Methaqualone;\n\n5. Gamma-Hydroxybutyric Acid, also known as GHB, gamma-\n\nhydroxybutyrate, 4-hydroxybutyrate, 4-hydroxybutanoic acid, sodium\na different\n\nschedule, any material, compound, mixture, or preparation which\n\ncontains any quantity of the following substances having stimulant\n\nor depressant effect on the central nervous system:\n\n1. Fenethylline;\n\n2. Mecloqualone;\n\n3. N-ethylamphetamine;\n\n4. Methaqualone;\n\n5. Gamma-Hydroxybutyric Acid, also known as GHB, gamma-\n\nhydroxybutyrate, 4-hydroxybutyrate, 4-hydroxybutanoic acid, sodium\n\noxybate, and sodium oxybutyrate;\n\n6. Gamma-Butyrolactone (GBL) as packaged, marketed,\n\nmanufactured or promoted for human consumption, with the exception\n\nof legitimate food additive and manufacturing purposes;\n\n7. Gamma Hydroxyvalerate (GHV) as packaged, marketed, or\n\nmanufactured for human consumption, with the exception of legitimate\n\nfood additive and manufacturing purposes;\n\n8. Gamma Valerolactone (GVL) as packaged, marketed, or\n\nmanufactured for human consumption, with the exception of legitimate\n\nfood additive and manufacturing purposes;\n\n9. 1,4 Butanediol (1,4 BD or BDO) as packaged, marketed,\n\nmanufactured, or promoted for human consumption with the exception\n\nof legitimate manufacturing purposes; or\n\n10. N-ethylpentylone.\n\nE. 1. The following industrial uses of Gamma-Butyrolactone,\n\nGamma Hydroxyvalerate, Gamma Valerolactone, or 1,4 Butanediol are\n\nexcluded from all schedules of controlled substances under this\n\ntitle:\n\na. pesticides,\n\nb. photochemical etching,\n\nc. electrolytes of small batteries or capacitors,\n\nd. viscosity modifiers in polyurethane,\n\ne. surface etching of metal coated plastics,\n\nf. organic paint disbursements for water soluble inks,\n\ng. pH regulators in the dyeing of wool and polyamide\n\nfibers,\n\nh. foundry chemistry as a catalyst during curing,\n\ni. curing agents in many coating systems based on\n\nurethanes and amides,\n\nj. additives and flavoring agents in food, confectionary,\n\nand beverage products,\n\nk. synthetic fiber and clothing production,\n\nl. tetrahydrofuran production,\n\nm. gamma butyrolactone production,\n\nn. polybutylene terephthalate resin production,\n\no. polyester raw materials for polyurethane elastomers\n\nand foams,\n\np. coating resin raw material, and\n\nq. as an intermediate in the manufacture of other\n\nchemicals and pharmaceuticals.\n\n2. At the request of any person, the Director of the Oklahoma\n\nState Bureau of Narcotics and Dangerous Drugs Control may exempt any\n\nother product containing Gamma-Butyrolactone, Gamma Hydroxyvalerate,\n\nGamma Valerolactone, or 1,4 Butanediol from being included as a\n\nSchedule I controlled substance if such product is labeled,\n\nmarketed, manufactured and distributed for legitimate industrial use\n\nin a manner that reduces or eliminates the likelihood of abuse.\n\n3. In making a determination regarding an industrial product,\n\nthe Director, after notice and hearing, shall consider the\n\nfollowing:\n\na. the history and current pattern of abuse,\n\nb. the name and labeling of the product,\n\nc. the intended manner of distribution, advertising and\n\npromotion of the product, and\n\nd. other factors as may be relevant to and consistent\n\nwith the public health and safety.\n\n4. The hearing shall be held in accordance with the procedures\n\nof the Administrative Procedures Act.\n\nF. Any material, compound, mixture, or preparation, whether\n\nproduced directly or indirectly from a substance of vegetable origin\n\nor independently by means of chemical synthesis, or by a combination\n\nof extraction and chemical synthesis, that contains any quantity of\n\nthe following substances, or that contains any of their salts,\n\nisomers, and salts of isomers when the existence of these salts,\n\nisomers, and salts of isomers is possible within the specific\n\nchemical designation:\n\n1. JWH-004;\n\n2. JWH-007;\n\n3. JWH-009;\n\n4. JWH-015;\n\n5. JWH-016;\n\n6. JWH-018;\n\n7. JWH-019;\n\n8. JWH-020;\n\n9. JWH-030;\n\n10. JWH-046;\n\n11. JWH-047;\n\n12. JWH-048;\n\n13. JWH-049;\n\n14. JWH-050;\n\n15. JWH-070;\nubstances, or that contains any of their salts,\n\nisomers, and salts of isomers when the existence of these salts,\n\nisomers, and salts of isomers is possible within the specific\n\nchemical designation:\n\n1. JWH-004;\n\n2. JWH-007;\n\n3. JWH-009;\n\n4. JWH-015;\n\n5. JWH-016;\n\n6. JWH-018;\n\n7. JWH-019;\n\n8. JWH-020;\n\n9. JWH-030;\n\n10. JWH-046;\n\n11. JWH-047;\n\n12. JWH-048;\n\n13. JWH-049;\n\n14. JWH-050;\n\n15. JWH-070;\n\n16. JWH-071;\n\n17. JWH-072;\n\n18. JWH-073;\n\n19. JWH-076;\n\n20. JWH-079;\n\n21. JWH-080;\n\n22. JWH-081;\n\n23. JWH-082;\n\n24. JWH-094;\n\n25. JWH-096;\n\n26. JWH-098;\n\n27. JWH-116;\n\n28. JWH-120;\n\n29. JWH-122;\n\n30. JWH-145;\n\n31. JWH-146;\n\n32. JWH-147;\n\n33. JWH-148;\n\n34. JWH-149;\n\n35. JWH-150;\n\n36. JWH-156;\n\n37. JWH-167;\n\n38. JWH-175;\n\n39. JWH-180;\n\n40. JWH-181;\n\n41. JWH-182;\n\n42. JWH-184;\n\n43. JWH-185;\n\n44. JWH-189;\n\n45. JWH-192;\n\n46. JWH-193;\n\n47. JWH-194;\n\n48. JWH-195;\n\n49. JWH-196;\n\n50. JWH-197;\n\n51. JWH-198;\n\n52. JWH-199;\n\n53. JWH-200;\n\n54. JWH-201;\n\n55. JWH-202;\n\n56. JWH-203;\n\n57. JWH-204;\n\n58. JWH-205;\n\n59. JWH-206;\n\n60. JWH-207;\n\n61. JWH-208;\n\n62. JWH-209;\n\n63. JWH-210;\n\n64. JWH-211;\n\n65. JWH-212;\n\n66. JWH-213;\n\n67. JWH-234;\n\n68. JWH-235;\n\n69. JWH-236;\n\n70. JWH-237;\n\n71. JWH-239;\n\n72. JWH-240;\n\n73. JWH-241;\n\n74. JWH-242;\n\n75. JWH-243;\n\n76. JWH-244;\n\n77. JWH-245;\n\n78. JWH-246;\n\n79. JWH-248;\n\n80. JWH-249;\n\n81. JWH-250;\n\n82. JWH-251;\n\n83. JWH-252;\n\n84. JWH-253;\n\n85. JWH-262;\n\n86. JWH-292;\n\n87. JWH-293;\n\n88. JWH-302;\n\n89. JWH-303;\n\n90. JWH-304;\n\n91. JWH-305;\n\n92. JWH-306;\n\n93. JWH-307;\n\n94. JWH-308;\n\n95. JWH-311;\n\n96. JWH-312;\n\n97. JWH-313;\n\n98. JWH-314;\n\n99. JWH-315;\n\n100. JWH-316;\n\n101. JWH-346;\n\n102. JWH-348;\n\n103. JWH-363;\n\n104. JWH-364;\n\n105. JWH-365;\n\n106. JWH-367;\n\n107. JWH-368;\n\n108. JWH-369;\n\n109. JWH-370;\n\n110. JWH-371;\n\n111. JWH-373;\n\n112. JWH-386;\n\n113. JWH-387;\n\n114. JWH-392;\n\n115. JWH-394;\n\n116. JWH-395;\n\n117. JWH-397;\n\n118. JWH-398;\n\n119. JWH-399;\n\n120. JWH-400;\n\n121. JWH-412;\n\n122. JWH-413;\n\n123. JWH-414;\n\n124. JWH-415;\n\n125. CP-55, 940;\n\n126. CP-47, 497;\n\n127. HU-210;\n\n128. HU-211;\n\n129. WIN-55, 212-2;\n\n130. AM-2201;\n\n131. AM-2233;\n\n132. JWH-018 adamantyl-carboxamide;\n\n133. AKB48;\n\n134. JWH-122 N-(4-pentenyl)analog;\n\n135. MAM2201;\n\n136. URB597;\n\n137. URB602;\n\n138. URB754;\n\n139. UR144;\n\n140. XLR11;\n\n141. A-796,260;\n\n142. STS-135;\n\n143. AB-FUBINACA;\n\n144. AB-PINACA;\n\n145. PB-22;\n\n146. AKB48 N-5-Fluorpentyl;\n\n147. AM1248;\n\n148. FUB-PB-22;\n\n149. ADB-FUBINACA;\n\n150. BB-22;\n\n151. 5-Fluoro PB-22; or\n\n152. 5-Fluoro AKB-48.\n\nG. In addition to those substances listed in subsection F of\n\nthis section, unless specifically excepted or unless listed in\n\nanother schedule, any material, compound, mixture, or preparation\n\nwhich contains any quantity of a synthetic cannabinoid found to be\n\nin any of the following chemical groups:\n\n1. Naphthoylindoles: any compound containing a 3-(1-\n\nnaphthoyl)indole structure with or without substitution at the\n\nnitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl,\n\nalkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-\n\n(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-\n\n2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,\n\n(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or\n\nhalophenyl group, whether or not further substituted on the indole\n\nring to any extent, and whether or not substituted on the naphthyl\n\nring to any extent. Naphthoylindoles include, but are not limited\n\nto:\n\na. 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-\n\n200),\n\nb. 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201),\n\nc. 1-pentyl-3-(1-naphthoyl)indole (JWH-018),\n\nd. 1-butyl-3-(1-naphthoyl)indole (JWH-073),\n\ne. 1-pentyl-3-(4-methoxy-1-naphthoyl)indole (JWH-081),\n\nf. 1-propyl-2-methyl-3-(1-naphthoyl)indole (JWH-015),\nlimited\n\nto:\n\na. 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-\n\n200),\n\nb. 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201),\n\nc. 1-pentyl-3-(1-naphthoyl)indole (JWH-018),\n\nd. 1-butyl-3-(1-naphthoyl)indole (JWH-073),\n\ne. 1-pentyl-3-(4-methoxy-1-naphthoyl)indole (JWH-081),\n\nf. 1-propyl-2-methyl-3-(1-naphthoyl)indole (JWH-015),\n\ng. 1-hexyl-3-(1-naphthoyl)indole (JWH-019),\n\nh. 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122),\n\ni. 1-pentyl-3-(4-ethyl-1-naphthoyl)indole (JWH-210),\n\nj. 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398),\n\nk. 1-pentyl-2-methyl-3-(1-naphthoyl)indole (JWH-007),\n\nl. 1-pentyl-3-(7-methoxy-1-naphthoyl)indole (JWH-164),\n\nm. 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole\n\n(JWH-098),\n\nn. 1-pentyl-3-(4-fluoro-1-naphthoyl)indole (JWH-412),\n\no. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(1-\n\nnaphthoyl)indole (AM-1220),\n\np. 1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole\n\n(MAM-2201), or\n\nq. 1-(4-cyanobutyl)-3-(1-naphthoyl)indole (AM-2232);\n\n2. Naphthylmethylindoles: any compound containing a 1H-indol-3-\n\nyl-(1-naphthyl)methane structure with or without substitution at the\n\nnitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl,\n\nalkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-\n\n(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-\n\n2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,\n\n(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or\n\nhalophenyl group, whether or not further substituted on the indole\n\nring to any extent, and whether or not substituted on the naphthyl\n\nring to any extent. Naphthylmethylindoles include, but are not\n\nlimited to, (1-pentylindol-3-yl)(1-naphthyl)methane (JWH-175);\n\n3. Naphthoylpyrroles: any compound containing a 3-(1-\n\nnaphthoyl)pyrrole structure with or without substitution at the\n\nnitrogen atom of the pyrrole ring by an alkyl, haloalkyl,\n\ncyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl,\n\nhalobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-\n\nmorpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-\n\nmorpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl,\n\nphenyl, or halophenyl group, whether or not further substituted on\n\nthe pyrrole ring to any extent, and whether or not substituted on\n\nthe naphthyl group to any extent. Naphthoylpyrroles include, but\n\nare not limited to:\n\na. 1-hexyl-2-phenyl-4-(1-naphthoyl)pyrrole (JWH-147),\n\nb. 1-pentyl-5-(2-methylphenyl)-3-(1-naphthoyl)pyrrole\n\n(JWH-370),\n\nc. 1-pentyl-3-(1-naphthoyl)pyrrole (JWH-030), or\n\nd. 1-hexyl-5-phenyl-3-(1-naphthoyl)pyrrole (JWH-147);\n\n4. Naphthylideneindenes: any compound containing a 1-(1-\n\nnaphthylmethylene)indene structure with or without substitution at\n\nthe 3-position of the indene ring by an alkyl, haloalkyl,\n\ncyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl,\n\nhalobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-\n\nmorpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-\n\nmorpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl,\n\nphenyl, or halophenyl group, whether or not further substituted on\n\nthe indene group to any extent, and whether or not substituted on\n\nthe naphthyl group to any extent. Naphthylmethylindenes include,\n\nbut are not limited to, (1-[(3-pentyl)-1H-inden-1-\n\nylidene)methyl]naphthalene (JWH-176);\n\n5. Phenylacetylindoles: any compound containing a 3-\n\nphenylacetylindole structure with or without substitution at the\n\nnitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl,\n\nalkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-\n\n(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-\n\n2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,\n\n(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or\n\nhalophenyl group, whether or not further substituted on the indole\nn at the\n\nnitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl,\n\nalkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-\n\n(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-\n\n2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,\n\n(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or\n\nhalophenyl group, whether or not further substituted on the indole\n\nring to any extent, and whether or not substituted on the phenyl\n\nring to any extent. Phenylacetylindoles include, but are not\n\nlimited to:\n\na. 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250),\n\nb. 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole\n\n(RCS-8),\n\nc. 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203),\n\nd. 1-pentyl-3-(2-methylphenylacetyl)indole (JWH-251),\n\ne. 1-pentyl-3-(4-methoxyphenylacetyl)indole (JWH-201), or\n\nf. 1-pentyl-3-(3-methoxyphenylacetyl)indole (JWH-302);\n\n6. Cyclohexylphenols: any compound containing a 2-(3-\n\nhydroxycyclohexyl)phenol structure with or without substitution at\n\nthe 5-position of the phenolic ring by an alkyl, haloalkyl,\n\ncyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl,\n\nhalobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-\n\nmorpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-\n\nmorpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl,\n\nphenyl, or halophenyl group, and whether or not further substituted\n\non the cyclohexyl ring to any extent. Cyclohexylphenols include,\n\nbut are not limited to:\n\na. 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-\n\nhydroxycyclohexyl]-phenol (CP-47,497),\n\nb. 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-\n\nphenol (cannabicyclohexanol; CP-47,497 C8 homologue),\n\nor\n\nc. 5-(1,1-dimethylheptyl)-2-[(1R,2R)-5-hydroxy-2-(3-\n\nhydroxypropyl)cyclohexyl]-phenol (CP 55, 940);\n\n7. Benzoylindoles: any compound containing a 3-(benzoyl)indole\n\nstructure with or without substitution at the nitrogen atom of the\n\nindole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,\n\ncycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-\n\n2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-\n\npyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,\n\n(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or\n\nhalophenyl group, whether or not further substituted on the indole\n\nring to any extent, and whether or not substituted on the phenyl\n\ngroup to any extent. Benzoylindoles include, but are not limited\n\nto:\n\na. 1-pentyl-3-(4-methoxybenzoyl)indole (RCS-4),\n\nb. 1-[2-(4-morpholinyl)ethyl]-2-methyl-3-(4-\n\nmethoxybenzoyl)indole (Pravadoline or WIN 48, 098),\n\nc. 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM-694),\n\nd. 1-pentyl-3-(2-iodobenzoyl)indole (AM-679), or\n\ne. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(2-\n\niodobenzoyl)indole (AM-2233);\n\n8. Cyclopropoylindoles: Any compound containing a 3-\n\n(cyclopropoyl)indole structure with substitution at the nitrogen\n\natom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,\n\ncycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-\n\n2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-\n\npyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,\n\n(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or\n\nhalophenyl group, whether or not further substituted in the indole\n\nring to any extent and whether or not substituted in the\n\ncyclopropoyl ring to any extent. Cyclopropoylindoles include, but\n\nare not limited to:\n\na. 1-pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole\n\n(UR-144),\n\nb. 1-(5-chloropentyl)-3-(2,2,3,3-\n\ntetramethylcyclopropoyl)indole (5Cl-UR-144), or\n\nc. 1-(5-fluoropentyl)-3-(2,2,3,3-\n\ntetramethylcyclopropoyl)indole (XLR11);\n\n9. Indole Amides: Any compound containing a 1H-Indole-3-\n\ncarboxamide structure with or without substitution at the nitrogen\n\natom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,\n\ncycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-\n-(2,2,3,3-\n\ntetramethylcyclopropoyl)indole (5Cl-UR-144), or\n\nc. 1-(5-fluoropentyl)-3-(2,2,3,3-\n\ntetramethylcyclopropoyl)indole (XLR11);\n\n9. Indole Amides: Any compound containing a 1H-Indole-3-\n\ncarboxamide structure with or without substitution at the nitrogen\n\natom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,\n\ncycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-\n\n2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-\n\npyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,\n\n(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or\n\nhalophenyl group, whether or not substituted at the carboxamide\n\ngroup by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl,\n\ncycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl-\n\n1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3-\n\ndimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not\n\nfurther substituted in the indole, adamantyl, naphthyl, phenyl,\n\npyrrole, quninolinyl, or cycloalkyl rings to any extent. Indole\n\nAmides include, but are not limited to:\n\na. N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide\n\n(2NE1),\n\nb. N-(1-adamantyl)-1-(5-fluoropentyl-1H-indole-3-\n\ncarboxamide (STS-135),\n\nc. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-\n\nindole-3-carboxamide (ADBICA),\n\nd. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-\n\nfluoropentyl)-1H-indole-3-carboxamide (5F-ADBICA),\n\ne. N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide\n\n(NNE1),\n\nf. 1-(5-fluoropentyl)-N-(naphthalene-1-yl)-1H-indole-3-\n\ncarboxamide (5F-NNE1),\n\ng. N-benzyl-1-pentyl-1H-indole-3-carboxamide (SDB-006),\n\nor\n\nh. N-benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide\n\n(5F-SDB-006);\n\n10. Indole Esters: Any compound containing a 1H-Indole-3-\n\ncarboxylate structure with or without substitution at the nitrogen\n\natom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,\n\ncycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-\n\n2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-\n\npyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl,\n\n(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or\n\nhalophenyl group, whether or not substituted at the carboxylate\n\ngroup by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl,\n\ncycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl-\n\n1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3-\n\ndimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not\n\nfurther substituted in the indole, adamantyl, naphthyl, phenyl,\n\npyrrole, quinolinyl, or cycloalkyl rings to any extent. Indole\n\nEsters include, but are not limited to:\n\na. quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB-\n\n22),\n\nb. quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-\n\ncarboxylate (5F-PB-22),\n\nc. quinolin-8-yl 1-(cyclohexylmethyl)-1H-indole-3-\n\ncarboxylate (BB-22),\n\nd. naphthalen-1-yl 1-(4-fluorobenzyl)-1H-indole-3-\n\ncarboxylate (FDU-PB-22), or\n\ne. naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-\n\ncarboxylate (NM2201);\n\n11. Adamantanoylindoles: Any compound containing an\n\nadamantanyl-(1H-indol-3-yl)methanone structure with or without\n\nsubstitution at the nitrogen atom of the indole ring by an alkyl,\n\nhaloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,\n\nbenzyl, halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-\n\nmorpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-\n\nmorpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl,\n\nphenyl, or halophenyl group, whether or not further substituted in\n\nthe indole ring to any extent and whether or not substituted in the\n\nadamantyl ring to any extent. Adamantanoylindoles include, but are\n\nnot limited to:\n\na. adamantan-1-yl[1-[(1-methyl-2-piperidinyl)methyl]-1H-\n\nindol-3-yl]methanone (AM1248), or\n\nb. adamantan-1-yl-(1-pentyl-1H-indol-3-yl)methanone (AB-\n\n001);\nl, 1-methylazepanyl,\n\nphenyl, or halophenyl group, whether or not further substituted in\n\nthe indole ring to any extent and whether or not substituted in the\n\nadamantyl ring to any extent. Adamantanoylindoles include, but are\n\nnot limited to:\n\na. adamantan-1-yl[1-[(1-methyl-2-piperidinyl)methyl]-1H-\n\nindol-3-yl]methanone (AM1248), or\n\nb. adamantan-1-yl-(1-pentyl-1H-indol-3-yl)methanone (AB-\n\n001);\n\n12. Carbazole Ketone: Any compound containing (9H-carbazole-3-\n\nyl) methanone structure with or without substitution at the nitrogen\n\natom of the carbazole ring by an alkyl, haloalkyl, cyanoalkyl,\n\nalkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-\n\n(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-\n\n2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl,\n\n(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or\n\nhalophenyl group, with substitution at the carbon of the methanone\n\ngroup by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl,\n\ncycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl-\n\n1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3-\n\ndimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not\n\nfurther substituted at the carbazole, adamantyl, naphthyl, phenyl,\n\npyrrole, quinolinyl, or cycloalkyl rings to any extent. Carbazole\n\nKetones include, but are not limited to, naphthalen-1-yl(9-pentyl-\n\n9H-carbazol-3-yl)methanone (EG-018);\n\n13. Benzimidazole Ketone: Any compound containing\n\n(benzimidazole-2-yl) methanone structure with or without\n\nsubstitution at either nitrogen atom of the benzimidazole ring by an\n\nalkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,\n\ncycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-2-\n\npiperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-\n\npyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl,\n\n(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or\n\nhalophenyl group, with substitution at the carbon of the methanone\n\ngroup by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl,\n\ncycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl-\n\n1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3-\n\ndimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not\n\nfurther substituted in the benzimidazole, adamantyl, naphthyl,\n\nphenyl, pyrrole, quinolinyl, or cycloalkyl rings to any extent.\n\nBenzimidazole Ketones include, but are not limited to:\n\na. naphthalen-1-yl(1-pentyl-1H-benzo[d]imidazol-2-\n\nl)methanone (JWH-018 benzimidazole analog), or\n\nb. (1-(5-fluoropentyl)-1H-benzo[d]imidazol-2-\n\nyl)(naphthalen-1-yl)methanone (FUBIMINA); and\n\n14. Modified by Replacement: any compound defined in this\n\nsubsection that is modified by replacement of a carbon with nitrogen\n\nin the indole, naphthyl, indene, benzimidazole, or carbazole ring.\n\nH. Any prescription drug approved by the federal Food and Drug\n\nAdministration under the provisions of Section 505 of the Federal\n\nFood, Drug and Cosmetic Act, Title 21 of the United States Code,\n\nSection 355, that is designated, rescheduled or deleted as a\n\ncontrolled substance under federal law by the United States Drug\n\nEnforcement Administration shall be excluded from Schedule I and\n\nshall be prescribed, distributed, dispensed or used in accordance\n\nwith federal law upon the issuance of a notice, final rule or\n\ninterim final rule by the United States Drug Enforcement\n\nAdministration designating, rescheduling or deleting as a controlled\n\nsubstance such a drug product under federal law, unless and until\n\nthe State Board of Pharmacy takes action pursuant to Section 2-201\n\nof this title. If the Board of Pharmacy does not take action\n\npursuant to Section 2-201 of this title, the drug product shall be\n\ndeemed to be designated, rescheduled or deleted as a controlled\n\nsubstance in accordance with federal law and in compliance with the\n\nUniform Controlled Dangerous Substances Act.","path":["OK Code","Title 63"],"source_url":"https://www.oklegislature.gov/OK_Statutes/CompleteTitles/os63.pdf","current_through":"2026-08-14","vintage":"open-us-law v2026.08, retrieved 2026-09-14","retrieved_at":"2026-09-14T18:32:36Z","sha256":"d08118104d610d2f33411e4c3c188aaea3f881fb5ddff056ebfdc3831fe955c1","source_id":"us-ok","stale":false,"prev":"us-ok/okla.-stat.-tit.-63-63-2-203","next":"us-ok/okla.-stat.-tit.-63-63-2-205"},"notice":"GroundRules: Original legal text. Not legal advice."}